pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Trump’s vaccine executive order likely erodes public trust, says epidemiologist

Aug 11, 2026·read at STAT ↗RegulatoryNegative

President Trump signed an executive order that claims to restore confidence in childhood vaccines by scaling back state mandates and trimming the recommended schedule from 18 diseases to 11.

The opinion piece argues the measure actually targets parents who are unsure about vaccines, presenting the revised schedule as a new "gold standard" while the government simultaneously changes long‑standing recommendations.

A June KFF poll identified a "malleable middle" of 31% of adults whose views on vaccine information are inconsistent; among parents who delay or skip shots, 45% fall in this group, suggesting the order could further weaken trust among the most hesitant.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Trump says his executive order should restore trust in vaccines. It does the exact opposite”

read at STAT ↗
1,226 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Vaccines20Vaccine11Monoclonal Antibody2GLP-1 receptorObesity

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 5Texas AG investigating energy drinksSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Vaderis nets $152M series B; Epicrispr adds $90MFierce Biotech
  • 6d agoEarnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launchBioPharma Dive
  • Jul 20HHS vaccine committee quietly gets new charterSTAT